Dimethylamine

Dimethylamine

SCHEMBL7954889

CNC.Cc1nc(-c2ccccc2)no1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.67
PLK1 P53350 1/20 0.58
NOTUM Q6P988 2/20 0.58
NR1H4 Q96RI1 3/20 0.57
NPC1 O15118 3/20 0.56
RAB9A P51151 3/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
TUBB4A P04350 1/20 0.53
TUBB P07437 1/20 0.53
TUBA3C P0DPH7 1/20 0.53
TUBA1B P68363 1/20 0.53
TUBA4A P68366 1/20 0.53
TUBB4B P68371 1/20 0.53
TUBB3 Q13509 1/20 0.53
TUBB2A Q13885 1/20 0.53
TUBB8 Q3ZCM7 1/20 0.53
TUBA3E Q6PEY2 1/20 0.53
TUBA1A Q71U36 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL255502 0.94 L3MBTL1 (0.74) L3MBTL1PLK1NOTUMNR1H4NPC1
SCHEMBL4718445 0.87 L3MBTL1 (0.65) L3MBTL1PLK1NOTUMNR1H4NPC1
SCHEMBL13415301 0.83 L3MBTL1 (0.69) L3MBTL1PLK1NR1H4NPC1RAB9A
SCHEMBL6656268 0.81 NR1H4 (0.68) L3MBTL1NR1H4NPC1RAB9ANFKB1
SCHEMBL13130238 0.80 L3MBTL1 (1.00) L3MBTL1PLK1NPC1RAB9ACA12
SCHEMBL7390745 0.79 PLK1 (0.61) L3MBTL1PLK1NR1H4NPC1RAB9A
SCHEMBL2967349 0.78 L3MBTL1 (0.62) L3MBTL1PLK1NR1H4NPC1RAB9A
SCHEMBL8311929 0.78 L3MBTL1 (0.72) L3MBTL1PLK1NPC1RAB9ATUBB4A
Dimethylamine SCHEMBL7961743 0.78 SMN1; SMN2 (0.67) L3MBTL1NR1H4NPC1RAB9ANFKB1
SCHEMBL14520138 0.77 TUBB4A (0.61) L3MBTL1NOTUMNR1H4NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277872-B1 ANTIISCHEMIC AGENTS; BRAIN DISORDERS BOEHRINGER INGELHEIM KG (DE) 2001-08-21 US disclosed